Singapore insurance company offers complimentary COVID-19 and dengue fever special insurance coverage

0
131

SINGAPORE – In light of the on-going threat of the coronavirus disease 2019 (COVID-19) and recent developments and rise of dengue fever cases in Singapore, Maybank and its insurance arm Etiqa Singapore are stepping up and pledging to provide a 30-day special insurance cover to all eligible customers of Maybank and Etiqa Singapore, free of charge.

Available for enrolment online from February 26 till 20 March, the special coverage provides a lump sum S$3,000 Diagnosis Benefit if the customer is diagnosed with the coronavirus Disease (COVID-19) or dengue fever. The 30-day complimentary cover commences on the date of successful enrolment and will expire automatically on the 30th day of enrolment, or upon maximum payout.

In the event that the customer is diagnosed with both COVID-19 and dengue fever within the 30-day coverage period, Etiqa is providing a lump sum payout of S$3,000 each. The total maximum payable amount is S$6,000 per eligible customer.

Customers who wish to continue their coverage beyond the 30-day complimentary coverage period may consider purchasing an enhanced personal accident policy from Etiqa for an extended cover for COVID-19 and dengue fever.

Sue Chi Kong, chief executive officer of Etiqa Singapore said, “The health and well-being of our customers, people and community is important to us. In view of the fast-evolving situations with the coronavirus and the mosquito-borne dengue disease, we are committed to supporting our people during this challenging period.”

“We believe this special COVID-19 and dengue fever cover, in addition to the financial assistance benefit we rolled out earlier for our eligible life customers, will provide adequate protection and assurance to our people. In the unfortunate event in which they catch either or both virus and/or disease, their financial impact can be minimised so they can maintain their normal lifestyles as much as possible,” added Sue.

LEAVE A REPLY

Please enter your comment!
Please enter your name here